±±Ê¦´óϸ°ûÉúÎïѧ£º 8&qZ0GLaT
Ò»¡¢ Ãû´Ê½âÊÍ£º ?WqT[MnK
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© +{f:cea (1
2£® PCR£¨96£© GkTiDm?
3£® ·ºËØ£¨ubquitin£©£¨96£© VoWNW
4£® °é·Ö×Ó£¨chapron£©£¨96£© _n50C"X=&(
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© MS
81sN\d
6£® DG£IP3£¨96£© 'R'*kxf
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© SVh 7zh
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© FE (ev 9@
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© Vy Xhl;
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© f=r<nb'H
11£® Transformation£¨92£© R\G0'?h
>
12£® TransfectionתȾ£¨92£© ~O
oidKT
13£® Transcytosis×ªÒÆ×÷Óã¨92£© jD<{t
14£® Transductionתµ¼£¨92£© ZQ%'`q\c
15£® Transdetermination£¨92£© 0uOkMuy<
16£® Transdifferentiation£¨92£© d"*uBVzXm
17£® Transgenic animalת»ùÒò¶¯Î92£© 0z
lb0[
18£® Rb£1£¨92£© C.Kh[V\Ut
19£® P53£¨92¡¢91£© %,}A@H,
20£® C£jun£¨92£© i1NY9br
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© Oj3.q#)`Z
22£® °ûÄÚÌ壨99£© ff,pvk8N5
23£® Cyclin dependent kinase inhibitor(CDKI)(99) @s ?
24£® G£protein£¨91£© P2BWuhF
25£® Restriction point£¨91£© 2Mc3|T4)U
26£® Antipost£¨91£© Zw
5Ni Xj
27£® Capping£¨91£© Z<1FSk,[
28£® TATAbox£¨91£© Rg\z<wPBG
29£® cDNA library£¨90£© :cem,#(=
30£® Aritotic apparatus£¨90£© PV'x+bN5
31£® ¿çĤÐźŠtransmembrane signal£¨90£© AS'R?aX|C
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© CrC^1K
33£® Nuclear lamina£¨90£© %Gz0^[+
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© {5U{8b]k
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© QdH\LL^8R4
36£® ϸ°û·Ö»¯£¨00£© =9'RM>
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© :~e>Ob[,"
38£® ¿Ë¡£¨00£© D/Z6C&/I
39£® »ùÒò×飨00£© c}Ft^Il
40£® Caspase£¨00£© LSa,1{
41£® ת¼Òò×Ó£¨00£© Se:.
4<
42£® ÅßÌ¥¸Éϸ°û£¨01£© >kj`7GA
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© R&8Iz
yM
44£® DNAоƬ£¨01£© kO.%9wFbz
¶þ¡¢ ÎÊ´ðÌ⣺ 2h|MXI\g
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© 8;b(0^
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© .b3Qfxc>
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© |% F=po>w
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© <r.)hT"0
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© KyVQh8
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© #a/5SZP
Z\
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© 6Z>FTz_
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© q}`${3qQ3
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© _GXk0Ia3`
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© 3QV *%
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© ?J%1#1L"/
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© V/%>4GYnC
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© oI0M%/aM
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© (yu/l6[
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹ØÏµ£¨95£© 9v;Vv0k_
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© qW$<U3u}
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æä¹¦ÄÜ£¨93£© gFeO}otm
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© N+m)/x
=:
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© v6=RY<l"m
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æä¶¨Î»¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© _D+}q_
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäĿǰËùÖªµÄ¹¦ÄÜ£¨01£© %7"q"A r[
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖØµãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© 8|):`u
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© w,.+IV$Kk
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© Sc>,lIM
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© ?zeJ#i
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆÚµÄµ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© 3*]eigi)
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹ØÏµ£¨91£© =[H;orMr
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© Hc!
mB
29£® ÊÔÊöºáÎÆ¼¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© Lrta/SU*
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æä¹¦ÄÜ£¨95£© ta35 K"
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© 33o9Yg|J~
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© 98j>1"8
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£©
&